Abbott's Alere resolves U.S. diagnostic device probe for $33.2 million
BOSTON (Reuters) - Alere Inc has agreed to pay $33.2 million to resolve claims it knowingly sold unreliable diagnostic testing devices to hospitals prior to its acquisition by Abbott Laboratories last year, the U.S. Justice Department said on Friday.
from Reuters: Health News http://reut.rs/2pyPfY8
http://bit.ly/2zwRqiM